Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -10.40% is 55% above its 5-year average of -23.31%, near the high end of its 5-year range (-75.43%–2.11%).
14.23% below its 12-month average of -9.10%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -14.98%.
NET PROFIT MARGIN
-10.40%
NET PROFIT MARGIN AVG TTM
-9.10%
NET PROFIT MARGIN AVG 3Y
-9.55%
NET PROFIT MARGIN AVG 5Y
-23.31%
NET PROFIT MARGIN AVG 10Y
-27.14%
NET PROFIT MARGIN AVG 15Y
-29.32%
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-14.23%
CURRENT VS 3Y AVG
-8.91%
CURRENT VS 5Y AVG
+55.38%
CURRENT VS 10Y AVG
+61.68%
CURRENT VS 15Y AVG
+64.53%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 729 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
LifeMD, Inc.
Market Cap
$147.97M
Net Profit Margin
-10.40%
TTM Avg
-9.10%
3Y Avg
-9.55%
5Y Avg
-23.31%
Market Cap
$148.36M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$149.51M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-85.02%
Market Cap
$144.89M
Net Profit Margin
-353.00%
TTM Avg
-161.48%
3Y Avg
-3791.01%
5Y Avg
-3351.38%
Market Cap
$143.10M
Net Profit Margin
-435.70%
TTM Avg
-1104.64%
3Y Avg
-1053.90%
5Y Avg
-4200.61%
Market Cap
$151.12M
Net Profit Margin
-39.55%
TTM Avg
-86.23%
3Y Avg
-76.35%
5Y Avg
-60.08%
Market Cap
$144.66M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-3984.32%
5Y Avg
-3047.80%
Market Cap
$149.66M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$151.58M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-6695.15%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| LifeMD, Inc. (LFMDP) | $147.97M | -10.40% | -9.10% | -9.55% | -23.31% |
| NervGen Pharma Corp. Common stock (NGEN)vs › | $148.36M | 0.00% | 0.00% | 0.00% | 0.00% |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $149.51M | 0.00% | 0.00% | 0.00% | -85.02% |
| Korsana Biosciences, Inc. (KRSA)vs › | $144.89M | -353.00% | -161.48% | -3791.01% | -3351.38% |
| Nyxoah S.A. (NYXH)vs › | $143.10M | -435.70% | -1104.64% | -1053.90% | -4200.61% |
| Codexis, Inc. (CDXS)vs › | $151.12M | -39.55% | -86.23% | -76.35% | -60.08% |
| Immuneering Corporation (IMRX)vs › | $144.66M | 0.00% | 0.00% | -3984.32% | -3047.80% |
| Anavex Life Sciences Corp. (AVXL)vs › | $149.66M | 0.00% | 0.00% | 0.00% | 0.00% |
| Cardiol Therapeutics Inc. (CRDL)vs › | $151.58M | 0.00% | 0.00% | 0.00% | -6695.15% |
| ALX Oncology Holdings Inc. (ALXO)vs › | $153.40M | 0.00% | 0.00% | 0.00% | -644.95% |
Operating Margin
-9.3%
Net Profit Margin
-10.4%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -14.98% |
| 2026-03-31 | -17.69% |
| 2025-12-31 | -3.19% |
| 2025-09-30 | -6.33% |
| 2025-06-30 | -3.33% |
| 2025-03-31 | 2.11% |
| 2024-12-31 | -0.17% |
| 2024-09-30 | -8.74% |
| 2024-06-30 | -13.57% |
| 2024-03-31 | -15.33% |
| 2023-12-31 | -8.32% |
| 2023-09-30 | -15.86% |
| 2023-06-30 | -18.73% |
| 2023-03-31 | -12.10% |
| 2022-12-31 | -42.44% |
| 2022-09-30 | -23.18% |
| 2022-06-30 | -42.74% |
| 2022-03-31 | -45.79% |
| 2021-12-31 | -66.06% |
| 2021-09-30 | -57.54% |
| 2021-06-30 | -75.43% |
| 2021-03-31 | -63.76% |
| 2020-12-31 | -250.13% |
| 2020-09-30 | -187.38% |
| 2020-06-30 | -37.17% |
| 2020-03-31 | -55.63% |
| 2019-12-31 | -18.04% |
| 2019-09-30 | -30.19% |
| 2019-06-30 | -30.32% |
| 2019-03-31 | -24.59% |
| 2018-12-31 | -32.60% |
| 2018-09-30 | -22.00% |
| 2018-06-30 | -29.79% |
| 2018-03-31 | 39.05% |
| 2017-12-31 | -14.93% |
| 2017-09-30 | -33.10% |
| 2017-06-30 | 66.60% |
| 2017-03-31 | -246.15% |
| 2016-12-31 | -62.77% |
| 2016-09-30 | -16.37% |
| 2016-06-30 | -16.29% |
| 2016-03-31 | -3.78% |
| 2015-12-31 | -13.59% |
| 2015-09-30 | 2.90% |
| 2015-06-30 | -7.58% |
| 2015-03-31 | 0.58% |
| 2014-12-31 | -90.28% |
| 2014-09-30 | -62.79% |
| 2014-06-30 | -36.37% |
| 2014-03-31 | -73.24% |
| 2013-12-31 | -44.57% |
| 2013-09-30 | -147.20% |
| 2013-06-30 | -4.91% |
| 2013-03-31 | -18.02% |
| 2012-12-31 | -61.58% |
| 2012-09-30 | -104.75% |
| 2012-06-30 | -82.10% |
| 2012-03-31 | -15.85% |
